| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |